Search for the latest updates on diabetes
News
FDA spurns Lilly, Boehringer diabetes drug, cites factory problem Reuters via Yahoo! News - 44 minutes
(Reuters) - Eli Lilly and Co and partner Boehringer Ingelheim said U.S. regulators have declined to approve their experimental diabetes drug ...
Manage alerts · Unsubscribe · Privacy Policy
Tip: To search for an exact phrase, put quotation marks around two or more words.
| You received this email because you subscribed to Yahoo! Alerts. |
No comments:
Post a Comment